公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2020 | Identification of serum cytokine clusters associated with outcomes in ovarian clear cell carcinoma | Yabuno A.; Matsushita H.; Hamano T.; Tan T.Z.; Shintani D.; Fujieda N.; Tan D.S.P.; RUBY YUN-JU HUANG ; Fujiwara K.; Kakimi K.; Hasegawa K. | Scientific Reports | 4 | 3 | |
2020 | Inflammatory and mitogenic signals drive interleukin 23 subunit alpha (IL23A) secretion independent of IL12B in intestinal epithelial cells | Lim K.S.; Ern Yong Z.W.; Wang H.; Tan T.Z.; RUBY YUN-JU HUANG ; Yamamoto D.; Inaki N.; Hazawa M.; Wong R.W.; Oshima H.; Oshima M.; Ito Y.; Chih-Cheng Voon X.D. | Journal of Biological Chemistry | 19 | 18 | |
2014 | Lgr5 marks stem/progenitor cells in ovary and tubal epithelia | Ng A.; Tan S.; Singh G.; Rizk P.; Swathi Y.; Tan T.Z.; RUBY YUN-JU HUANG ; Leushacke M.; Barker N. | Nature Cell Biology | 168 | 157 | |
2017 | ‘Lnc’-ing Wnt in female reproductive cancers: therapeutic potential of long non-coding RNAs in Wnt signalling | Ong M.S.; Cai W.; Yuan Y.; Leong H.C.; Tan T.Z.; Mohammad A.; You M.L.; Arfuso F.; Goh B.C.; Warrier S.; Sethi G.; Tolwinski N.S.; Lobie P.E.; Yap C.T.; Hooi S.C.; RUBY YUN-JU HUANG ; Kumar A.P. | British Journal of Pharmacology | 57 | 56 | |
2017 | Loss of discoidin domain receptor 1 (DDR1) via CpG methylation during EMT in epithelial ovarian cancer | Chung V.Y.; Tan T.Z.; Huang, R.-L.; Lai H.-C.; RUBY YUN-JU HUANG | Gene | 19 | 16 | |
2019 | Molecular Subtypes of Urothelial Bladder Cancer: Results from a Meta-cohort Analysis of 2411 Tumors | Tan T.Z.; Rouanne M.; Tan K.T.; RUBY YUN-JU HUANG ; Thiery J.-P. | European Urology | 185 | 168 | |
2021 | Putting the BRK on breast cancer: From molecular target to therapeutics | Ang H.L.; Yuan Y.; Lai X.; Tan T.Z.; Wang L.; Huang B.B.; Pandey V.; RUBY YUN-JU HUANG ; Lobie P.E.; Goh B.C.; Sethi G.; Yap C.T.; Chan C.W.; Lee S.C.; Kumar A.P. | Theranostics | 15 | 14 | |
2019 | Reply to Pontus Eriksson and Gottfrid Sj?dahl's Letter to the Editor re: Tuan Zea Tan, Mathieu Rouanne, Kien Thiam Tan, Ruby Yun-Ju Huang, Jean-Paul Thiery. Molecular Subtypes of Urothelial Bladder Cancer: Results from a Meta-cohort Analysis of 2411 Tumors. Eur Urol 2019;75:423–32 | Tan T.Z.; Rouanne M.; RUBY YUN-JU HUANG ; Thiery J.-P. | European Urology | 3 | 0 | |
2019 | The role of GRHL2 and epigenetic remodeling in epithelial–mesenchymal plasticity in ovarian cancer cells | Chung V.Y.; Tan T.Z.; Ye J.; Huang, R.-L.; Lai H.-C.; Kappei D.; Wollmann H.; Guccione E.; RUBY YUN-JU HUANG | Communications Biology | 51 | 48 | |
2020 | Single-cell analysis of EphA clustering phenotypes to probe cancer cell heterogeneity | Ravasio A.; Myaing M.Z.; Chia S.; Arora A.; Sathe A.; Cao E.Y.; Bertocchi C.; Sharma A.; Arasi B.; Chung V.Y.; Green A.C.; Tan T.Z.; Chen Z.; Ong H.T.; Iyer N.G.; RUBY YUN-JU HUANG ; DasGupta R.; Groves J.T.; Viasnoff V. | Communications Biology | 3 | 4 | |
2019 | SNAI1 recruits HDAC1 to suppress SNAI2 transcription during epithelial to mesenchymal transition | Sundararajan V.; Tan M.; Tan T.Z.; Ye J.; Thiery J.P.; RUBY YUN-JU HUANG | Scientific Reports | 30 | 29 | |
2020 | Snai1-driven sequential emt changes attributed by selective chromatin enrichment of RAD21 and GRHL2 | Sundararajan V.; Tan M.; Tan T.Z.; Pang Q.Y.; Ye J.; Chung V.Y.; RUBY YUN-JU HUANG | Cancers | 10 | 11 | |
2017 | Targeting the AXL signaling pathway in ovarian cancer | RUBY YUN-JU HUANG ; Antony J.; Tan T.Z.; Tan D.S.-P. | Molecular and Cellular Oncology | 13 | 0 | |
2018 | The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancer | Antony J.; Zanini E.; Kelly Z.; Tan T.Z.; Karali E.; Alomary M.; Jung Y.; Nixon K.; Cunnea P.; Fotopoulou C.; Paterson A.; Roy-Nawathe S.; Mills G.B.; RUBY YUN-JU HUANG ; Thiery J.P.; Gabra H.; Recchi C. | EMBO Reports | 26 | 29 |